The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4'-(Dimethylamino)-[1,1'-biphenyl]-3-yl)-4-(2-(2-ethoxyphenyl)hydrazono)-3-methyl-1H-pyrazol-5(4H)-one ID: ALA3417408
PubChem CID: 136934829
Max Phase: Preclinical
Molecular Formula: C26H27N5O2
Molecular Weight: 441.54
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOc1ccccc1N/N=C1\C(=O)N(c2cccc(-c3ccc(N(C)C)cc3)c2)N=C1C
Standard InChI: InChI=1S/C26H27N5O2/c1-5-33-24-12-7-6-11-23(24)27-28-25-18(2)29-31(26(25)32)22-10-8-9-20(17-22)19-13-15-21(16-14-19)30(3)4/h6-17,27H,5H2,1-4H3/b28-25-
Standard InChI Key: IFFIOZVIEUYJHY-FVDSYPCUSA-N
Molfile:
RDKit 2D
33 36 0 0 0 0 0 0 0 0999 V2000
-2.0570 7.5366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4704 13.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8194 8.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 1.4978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8149 12.7100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3914 10.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2432 15.2653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5570 7.5366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 3.0008 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3039 3.7494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6596 5.7324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5205 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3154 12.6682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3251 8.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9395 1.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0935 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3070 5.2502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3964 11.3470 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8958 11.3029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7427 15.3070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0456 5.7325 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5285 14.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6073 9.9824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4594 16.6257 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6589 16.6573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8325 17.6489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22 11 1 0
13 18 1 0
13 5 1 0
28 14 1 0
10 2 2 0
26 10 1 0
25 24 2 0
23 15 2 0
4 13 2 0
8 21 1 0
22 27 2 0
3 30 2 0
20 3 1 0
5 8 1 0
29 26 2 0
24 7 1 0
20 11 1 0
14 9 2 0
2 19 1 0
12 18 1 0
17 16 1 0
19 6 2 0
18 28 2 0
1 17 2 0
30 25 1 0
17 23 1 0
9 4 1 0
7 20 2 0
15 12 1 0
24 19 1 0
6 29 1 0
11 1 1 0
23 22 1 0
26 31 1 0
31 32 1 0
31 33 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 441.54Molecular Weight (Monoisotopic): 441.2165AlogP: 5.01#Rotatable Bonds: 7Polar Surface Area: 69.53Molecular Species: ACIDHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 5.50CX Basic pKa: 4.69CX LogP: 5.61CX LogD: 4.40Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.52Np Likeness Score: -1.56
References 1. Stornaiuolo M, La Regina G, Passacantilli S, Grassia G, Coluccia A, La Pietra V, Giustiniano M, Cassese H, Di Maro S, Brancaccio D, Taliani S, Ialenti A, Silvestri R, Martini C, Novellino E, Marinelli L.. (2015) Structure-based lead optimization and biological evaluation of BAX direct activators as novel potential anticancer agents., 58 (5): [PMID:25668341 ] [10.1021/jm501123r ]